Universal Health Services, Inc (NYSE: UHS) has a price-to-earnings ratio that is above its average at 10.99x. The stock has a 36-month beta value of 1.26. Opinions on the stock are mixed, with 6 analysts rating it as a “buy”, 2 as “overweight”, 10 as “hold”, and 0 as “sell”.
The public float for UHS is 52.44M, and at present, short sellers hold a 3.84% of that float. On February 12, 2026, the average trading volume of UHS was 695.93K shares.
UHS stock’s latest price update
Universal Health Services, Inc (NYSE: UHS)’s stock price has soared by 8.71% in relation to previous closing price of $212.78. Nevertheless, the company has seen a gain of 12.04% in its stock price over the last five trading days. defenseworld.net reported 2026-02-07 that AustralianSuper Pty Ltd lifted its stake in Universal Health Services, Inc. (NYSE: UHS) by 4.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 225,038 shares of the health services provider’s stock after acquiring an additional 10,548 shares during
UHS’s Market Performance
Universal Health Services, Inc (UHS) has seen a 12.04% rise in stock performance for the week, with a 12.31% gain in the past month and a 3.90% surge in the past quarter. The volatility ratio for the week is 4.59%, and the volatility levels for the past 30 days are at 3.16% for UHS. The simple moving average for the past 20 days is 11.80% for UHS’s stock, with a 17.03% simple moving average for the past 200 days.
Analysts’ Opinion of UHS
Many brokerage firms have already submitted their reports for UHS stocks, with Wells Fargo repeating the rating for UHS by listing it as a “Equal Weight”. The predicted price for UHS in the upcoming period, according to Wells Fargo is $235 based on the research report published on January 07, 2026 of the current year 2026.
Raymond James, on the other hand, stated in their research note that they expect to see UHS reach a price target of $270. The rating they have provided for UHS stocks is “Outperform” according to the report published on November 03rd, 2025.
BofA Securities gave a rating of “Underperform” to UHS, setting the target price at $185 in the report published on July 16th of the previous year.
UHS Trading at 6.80% from the 50-Day Moving Average
After a stumble in the market that brought UHS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.09% of loss for the given period.
Volatility was left at 3.16%, however, over the last 30 days, the volatility rate increased by 4.59%.
Insider Trading
Nimetz Warren J., the Director of Universal Health Services, Inc, sale 3,817 shares at $223.30 during a trade that took place back on Nov 11 ’25, which means that Nimetz Warren J. is holding 8,481 shares at $852,343 based on the most recent closing price.
Stock Fundamentals for UHS
Current profitability levels for the company are sitting at:
- 0.11% for the present operating margin
- 0.9% for the gross margin
The net margin for Universal Health Services, Inc stands at 0.08%. The total capital return value is set at 0.16%. Equity return is now at value 19.97%, with 9.26% for asset returns.
Based on Universal Health Services, Inc (UHS), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.38. The debt to equity ratio resting at 0.71. The interest coverage ratio of the stock is 12.7.
Currently, EBITDA for the company is $2.27 billion with net debt to EBITDA at 1.94. When we switch over and look at the enterprise to sales, we see a ratio of 1.17. The receivables turnover for the company is 6.57for trailing twelve months and the total asset turnover is 1.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.03.
Conclusion
To sum up, Universal Health Services, Inc (UHS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.